Literature DB >> 20951830

Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing.

Luigi Greco1, Marco Gobbetti, Renata Auricchio, Raffaella Di Mase, Francesca Landolfo, Francesco Paparo, Raffaella Di Cagno, Maria De Angelis, Carlo Giuseppe Rizzello, Angela Cassone, Gaetano Terrone, Laura Timpone, Martina D'Aniello, Maria Maglio, Riccardo Troncone, Salvatore Auricchio.   

Abstract

BACKGROUND & AIMS: Celiac disease (CD) is characterized by an inflammatory response to wheat gluten, rye, and barley proteins. Fermentation of wheat flour with sourdough lactobacilli and fungal proteases decreases the concentration of gluten. We evaluated the safety of daily administration of baked goods made from this hydrolyzed form of wheat flour to patients with CD.
METHODS: Patients were randomly assigned to consumption of 200 g per day of natural flour baked goods (NFBG) (80,127 ppm gluten; n = 6), extensively hydrolyzed flour baked goods (S1BG) (2480 ppm residual gluten; n = 2), or fully hydrolyzed baked goods (S2BG) (8 ppm residual gluten; n = 5) for 60 days.
RESULTS: Two of the 6 patients who consumed NFBG discontinued the challenge because of symptoms; all had increased levels of anti-tissue transglutaminase (tTG) antibodies and small bowel deterioration. The 2 patients who ate the S1BG goods had no clinical complaints but developed subtotal atrophy. The 5 patients who ate the S2BG had no clinical complaints; their levels of anti-tTG antibodies did not increase, and their Marsh grades of small intestinal mucosa did not change.
CONCLUSIONS: A 60-day diet of baked goods made from hydrolyzed wheat flour, manufactured with sourdough lactobacilli and fungal proteases, was not toxic to patients with CD. A combined analysis of serologic, morphometric, and immunohistochemical parameters is the most accurate method to assess new therapies for this disorder.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951830     DOI: 10.1016/j.cgh.2010.09.025

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  24 in total

Review 1.  Celiac disease: advances in treatment via gluten modification.

Authors:  Samantha Stoven; Joseph A Murray; Eric Marietta
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

2.  Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion.

Authors:  Ruggiero Francavilla; Maria De Angelis; Carlo Giuseppe Rizzello; Noemi Cavallo; Fabio Dal Bello; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

Review 3.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 4.  Latest in vitro and in vivo models of celiac disease.

Authors:  Samantha Stoven; Joseph A Murray; Eric V Marietta
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

5.  Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial.

Authors:  Prasenjit Das; Vishnubhatla Sreenivas; Siddhartha Datta Gupta; Subrat K Panda; Govind K Makharia
Journal:  Dig Dis Sci       Date:  2012-06-30       Impact factor: 3.199

6.  Protective effects of Acetobacter ghanensis against gliadin toxicity in intestinal epithelial cells with immunoregulatory and gluten-digestive properties.

Authors:  Caglar Doguer; Hande Akalan; Nazan Tokatlı Demirok; Berna Erdal; Rafet Mete; Turker Bilgen
Journal:  Eur J Nutr       Date:  2022-09-29       Impact factor: 4.865

7.  Reintroduction of gluten following flour transamidation in adult celiac patients: a randomized, controlled clinical study.

Authors:  Giuseppe Mazzarella; Virginia M Salvati; Gaetano Iaquinto; Rosita Stefanile; Federica Capobianco; Diomira Luongo; Paolo Bergamo; Francesco Maurano; Nicola Giardullo; Basilio Malamisura; Mauro Rossi
Journal:  Clin Dev Immunol       Date:  2012-07-31

8.  Fermentation of Gluten by Lactococcus lactis LLGKC18 Reduces its Antigenicity and Allergenicity.

Authors:  Kamel-Eddine El Mecherfi; Roberta Lupi; Mehdi Cherkaoui; Marcela A C Albuquerque; Svetoslav Dimitrov Todorov; Olivier Tranquet; Caroline Klingebiel; Hélène Rogniaux; Sandra Denery-Papini; Bernard Onno; Bernadette Dora Gombossy de Melo Franco; Colette Larré
Journal:  Probiotics Antimicrob Proteins       Date:  2021-06-03       Impact factor: 5.265

9.  New insights in celiac disease.

Authors:  David Branski
Journal:  Rambam Maimonides Med J       Date:  2012-01-31

Review 10.  The tip of the "celiac iceberg" in China: a systematic review and meta-analysis.

Authors:  Juanli Yuan; Jinyan Gao; Xin Li; Fahui Liu; Cisca Wijmenga; Hongbing Chen; Luud J W J Gilissen
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.